PLA2G4A and idiopathic pulmonary fibrosis: LPA (lysophosphatidic acid), a pro-fibrotic, inflammatory mediator and also a downstream metabolite of Phospholipase A2 (PLA2) signaling was found to be increased in both BAL fluid of IPF patients and bleomycin-treated mice.